Related Experiment Video
Updated: Aug 15, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Myalgia and cramps associated with zolmitriptan
Hortensia Alonso-Navarro1, Félix Javier Jiménez-Jiménez
1Servicio de Neurología, Hospital Universitario San Juan, Alicante, Spain.
Objective:
To report a patient with myalgia and cramps possibly induced by the antimigrainous agent zolmitriptan.
Case Report:
A 27-year-old woman with episodes of common migraine developed cramps and generalized myalgia after the use of intranasal zolmitriptan 5 mg to treat 3 episodes of migraine. This side effect had not occurred with oral zolmitriptan 2.5 mg.
Conclusion:
Myalgia and cramps should be considered a possible dose-dependent adverse effect of zolmitriptan.
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Skeletal Muscle Relaxants: Therapeutic Uses
